Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA panel will weigh benefits of J&J blood thinner against bleeding risks today
FDA panel will weigh benefits of J&J blood thinner against bleeding risks today
FDA panel will weigh benefits of J&J blood thinner against bleeding risks today
Submitted by
admin
on March 19, 2009 - 7:26am
Source:
Yahoo/AP
News Tags:
JNJ
rivaroxaban
blood thinners
FDA
Headline:
FDA panel will weigh benefits of J&J blood thinner against bleeding risks today
Do Not Allow Advertisers to Use My Personal information
